Navigation Links
PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
Date:3/12/2009

BOSTON, March 12 /PRNewswire-FirstCall/ -- Albert Liou, Corporate Vice President and General Manager, Asia/Pacific Region at PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will present "The True Value of Incorporating Asia into a Global Clinical Development Strategy" at the BioMedical Asia 2009 conference, to be held March 16 - 19, 2009 at the Suntec Singapore International Convention & Exhibition Centre in Singapore. Mr. Liou will discuss how biopharmaceutical companies can further expedite and improve the efficiency of studies in the Asia/Pacific region. He will also address the pros and cons of conducting clinical trials in Asia, specifically in China, Japan, South Korea and Taiwan. PAREXEL's presentation takes place on Wednesday, March 18 at 11:05 a.m. as part of the Clinical Operations and Partnering Track.

With 15 locations throughout the Asia/Pacific region, including an office in Singapore, PAREXEL helps clients address key challenges in conducting studies in the Asia/Pacific region and globally, including accessing diverse patient populations, navigating regulatory issues, identifying investigators, and ensuring data quality. PAREXEL has had a long-term commitment to providing a high level of standardization and quality clinical development services the Asia/Pacific region. For over 25 years, PAREXEL has been a proven and committed partner to pharmaceutical, biotechnology, and medical device companies looking to bring innovative new products to market. PAREXEL has extensive experience in providing comprehensive worldwide services to companies of all sizes. With deep expertise and capabilities in consulting, clinical research, eClinical technologies, and medical communications, PAREXEL has helped drive the success of thousands of its clients' development programs, and has assisted
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
2. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
3. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
4. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
5. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
7. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
11. PAREXEL International Announces 2-For-1 Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Cambridge Semantics was one of just 22 companies ... Capitol Hill, hosted by The Data Transparency ... showcase how innovative data management applications can address the requirements ... , Originally introduced in 2011 by Committee Chairman ... Warner (D-VA ), the DATA Act is designed to ...
(Date:5/22/2013)... 2013   Oligomerix, Inc. , a privately ... therapeutics for Alzheimer,s disease (AD) and related neurodegenerative ... B financing, which includes both issuance of new ... approximately $2.8M in new investments in the Company.  ... raise. Funding from the Series ...
(Date:5/22/2013)... 22, 2013  Superior Controls, Inc. has been ... Business NH Magazine.  For the past 22 years, ... distinguish themselves with extraordinary business and civic excellence. ... this honor," said Rick Pierro ... recognition, this award is a reflection of Superior ...
(Date:5/22/2013)... Genedata, a leading provider of advanced ... life science research, today announced AB Enzymes will ... bioinformatics platform for strain genome data management on ... Enzymes, one of the world’s oldest and best-known ... Selector accompanied by bioinformatics consulting services. Genedata Selector, ...
Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4
... Up 61%, Six-Month Net Revenues Up 40%, ETHEX Corporation Net Revenues Up 102% for Second Quarter ... ... for Six ... Months, ST. LOUIS, Nov. 20 KV Pharmaceutical Company,(NYSE: KVa/KVb) today reported preliminary ...
... PLEASANTON, Calif., Nov. 19 Thoratec,Corporation (Nasdaq: ... treat,cardiovascular disease, today announced the appointment of healthcare,executive ... effective January 1,2008. His appointment brings the Thoratec ... join the board,s compensation and option committee, is,executive ...
... Kline Report on Smart Coatings Cites Immediate Opportunities in ... Coatings, Cool Paint, and Smart Glass -, LITTLE ... and Medicaid that they will no longer reimburse expenses ... the paint and coatings industries to sell antimicrobial coatings,according ...
Cached Biology Technology:KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 2KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 3KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 4KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 5KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 6KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 7KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 8KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 9KV Pharmaceutical Company Reports Record Revenues for Fiscal 2008 Second Quarter and Six Months on a Preliminary Basis 10Thoratec Announces Appointment of Steven H. Collis to Board of Directors 2Thoratec Announces Appointment of Steven H. Collis to Board of Directors 3Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S. 2
(Date:5/23/2013)... year, carrying more than 284 million tons of cargo, transit ... in toll fees for the Panama Canal Authority. Each time ... water are used from Gatun Lake, which is also a ... the isthmus. , However, the advent of very large ... ships at sea, has demanded change. The Panama Canal is ...
(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
(Date:5/23/2013)... the overall health, development, and academic success of ... ensuring that all students have opportunities to engage ... vigorous or moderate-intensity physical activity, says a new ... estimates suggest that only about half of school-age ... health and development. The report recommends that ...
Breaking Biology News(10 mins):Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3
... 18th. The German research vessel Polarstern, operated by the ... the Helmholtz Association, will begin its 24th Arctic expedition ... nations will research the whole spectrum of current Arctic ... climate development, effects on the ecosystem ranging from bacteria ...
... N.H. University of New Hampshire professor Frederick Short ... the only environmental award of its kind given ... a project that restored eelgrass to coastal salt ponds ... efforts, this award from the p resident recognizes outstanding ...
... in French . For climatologists, part of ... what happened during previous periods of global climate change. ... 33.5 million years ago in the Late Eocene and Early ... falling and the hothouse warmth of the dinosaur age and ...
Cached Biology News:Research vessel Polarstern starts 24th Arctic season 2UNH researcher receives presidential environmental award 2When palm trees gave way to spruce trees 2
Rabbit Anti-JNK1/SAPK pan, Polyclonal Antibody...
...
Low melting point. Ideally suited for in gel enzymatic reactions. Gelling temp. 24-28C Melting temp. 65C. EEO 0.12 Resolution 0.5-20 kb; Rnase/Dnase: none detected....
QPRT Immunogen: QPRT (NP_055113, 198 a.a. ~ 298 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: